Cargando…

P079 Real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutation

Detalles Bibliográficos
Autores principales: Vincken, S., Knoop, C., Verbanck, S., Buyck, N., Vanderhelst, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184784/
http://dx.doi.org/10.1016/S1569-1993(22)00412-X